glp 1 drugs and vision problems π Optometrists are warning GLP-1 may pose these types of rare risks π β¬οΈ Details in comments GLP-1 Drugs and Ocular Disease:
Description
What CAGR is expected for GLP-1 sales in Latin America through 2031

WNT5a is required for normal ovarian follicle development and antagonizes gonadotropin responsiveness in granulosa cells by suppressing canonical WNT signaling

How I Monitor Thyroid Patients on GLP-1 Heres what I look for: Labs: I monitor TSH, T3, and T4 to ensure your thyroid stays stable on GLP-1

Zhao L, Cheng Z, Lu Y, Liu M, Chen H, Zhang M, et al
Having more options available to patients is a good thing, says Daniel Drucker, an endocrinologist at the University of Toronto whose research paved the way for GLP-1 drugs but who was not involved in the new studies
The company incurred $33 million of restructuring costs in Q1, primarily consisting of the write-downs related to its compounded GLP-1 supply chain "that now faces risk of obsolescence," Okupe said during the call
